Literature DB >> 33688077

Full methylation of H3K27 by PRC2 is dispensable for initial embryoid body formation but required to maintain differentiated cell identity.

Sara A Miller1,2, Manashree Damle1, Jongmin Kim1,2, Robert E Kingston1,2.   

Abstract

Polycomb repressive complex 2 (PRC2) catalyzes methylation of histone H3 on lysine 27 and is required for normal development of complex eukaryotes. The nature of that requirement is not clear. H3K27me3 is associated with repressed genes, but the modification is not sufficient to induce repression and, in some instances, is not required. We blocked full methylation of H3K27 with both a small molecule inhibitor, GSK343, and by introducing a point mutation into EZH2, the catalytic subunit of PRC2, in the mouse CJ7 cell line. Cells with substantively decreased H3K27 methylation differentiate into embryoid bodies, which contrasts with EZH2 null cells. PRC2 targets had varied requirements for H3K27me3, with a subset that maintained normal levels of repression in the absence of methylation. The primary cellular phenotype of blocked H3K27 methylation was an inability of altered cells to maintain a differentiated state when challenged. This phenotype was determined by H3K27 methylation in embryonic stem cells through the first 4 days of differentiation. Full H3K27 methylation therefore was not necessary for formation of differentiated cell states during embryoid body formation but was required to maintain a stable differentiated state.
© 2021. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Differentiation; EZH2; Embryoid body; H3K27 methylation; Maintenance; PRC2

Mesh:

Substances:

Year:  2021        PMID: 33688077      PMCID: PMC8077505          DOI: 10.1242/dev.196329

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  78 in total

1.  Elements of the polycomb repressor SU(Z)12 needed for histone H3-K27 methylation, the interface with E(Z), and in vivo function.

Authors:  Aswathy N Rai; Marcus L Vargas; Liangjun Wang; Erica F Andersen; Ellen L Miller; Jeffrey A Simon
Journal:  Mol Cell Biol       Date:  2013-10-07       Impact factor: 4.272

2.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

Review 3.  Differentiation of pluripotent embryonic stem cells into cardiomyocytes.

Authors:  Kenneth R Boheler; Jaroslaw Czyz; David Tweedie; Huang-Tian Yang; Sergey V Anisimov; Anna M Wobus
Journal:  Circ Res       Date:  2002-08-09       Impact factor: 17.367

Review 4.  Six Years (2012-2018) of Researches on Catalytic EZH2 Inhibitors: The Boom of the 2-Pyridone Compounds.

Authors:  Rossella Fioravanti; Giulia Stazi; Clemens Zwergel; Sergio Valente; Antonello Mai
Journal:  Chem Rec       Date:  2018-10-19       Impact factor: 6.771

Review 5.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

6.  Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia.

Authors:  Bowen Xu; Doan M On; Anqi Ma; Trevor Parton; Kyle D Konze; Samantha G Pattenden; David F Allison; Ling Cai; Shira Rockowitz; Shichong Liu; Ying Liu; Fengling Li; Masoud Vedadi; Stephen V Frye; Benjamin A Garcia; Deyou Zheng; Jian Jin; Gang Greg Wang
Journal:  Blood       Date:  2014-11-13       Impact factor: 25.476

7.  An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites.

Authors:  Peter J Skene; Steven Henikoff
Journal:  Elife       Date:  2017-01-16       Impact factor: 8.140

8.  GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells.

Authors:  Hao Xu; Linshi Zhang; Xiaohui Qian; Xiaohu Zhou; Yingcai Yan; Jiarong Zhou; Wenhao Ge; Mugahed Albahde; Weilin Wang
Journal:  Exp Ther Med       Date:  2019-08-02       Impact factor: 2.447

9.  Structural context of disease-associated mutations and putative mechanism of autoinhibition revealed by X-ray crystallographic analysis of the EZH2-SET domain.

Authors:  Stephen Antonysamy; Bradley Condon; Zhanna Druzina; Jeffrey B Bonanno; Tarun Gheyi; Feiyu Zhang; Iain MacEwan; Aiping Zhang; Sheela Ashok; Logan Rodgers; Marijane Russell; John Gately Luz
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

10.  S-Adenosyl-L-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells.

Authors:  Tsang-Pai Liu; Hsiang-Ling Lo; Li-Shan Wei; Heidi Hao-yun Hsiao; Pei-Ming Yang
Journal:  Anticancer Drugs       Date:  2015-02       Impact factor: 2.248

View more
  3 in total

Review 1.  Context-specific Polycomb mechanisms in development.

Authors:  Jongmin J Kim; Robert E Kingston
Journal:  Nat Rev Genet       Date:  2022-06-09       Impact factor: 59.581

Review 2.  Polycomb Repressive Complex 2 in Eukaryotes-An Evolutionary Perspective.

Authors:  Mallika Vijayanathan; María Guadalupe Trejo-Arellano; Iva Mozgová
Journal:  Epigenomes       Date:  2022-01-17

3.  LncRNA-Smad7 mediates cross-talk between Nodal/TGF-β and BMP signaling to regulate cell fate determination of pluripotent and multipotent cells.

Authors:  Xiaohui Kong; Kun Yan; Pujuan Deng; Haipeng Fu; Hongyao Sun; Wenze Huang; Shuangying Jiang; Junbiao Dai; Qiangfeng Cliff Zhang; Jun-Jie Gogo Liu; Qiaoran Xi
Journal:  Nucleic Acids Res       Date:  2022-10-14       Impact factor: 19.160

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.